{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T12:05:10Z","timestamp":1785153910611,"version":"3.55.0"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T00:00:00Z","timestamp":1775779200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001659","name":"German Research Foundation","doi-asserted-by":"publisher","award":["519747461"],"award-info":[{"award-number":["519747461"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Disease"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.nbd.2026.107396","type":"journal-article","created":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T17:23:42Z","timestamp":1776101022000},"page":"107396","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Elucidation of the influence of the CaV2.2 calcium channel on ALS disease progression in the SOD1*G93A mouse model"],"prefix":"10.1016","volume":"224","author":[{"given":"Katharina","family":"Wintz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul Luca","family":"Lechtape","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jannes","family":"Klenzendorf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Schemmert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J.","family":"Dingley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antje","family":"Willuweit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janine","family":"Kutzsche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1\u20132","key":"10.1016\/j.nbd.2026.107396_bb0005","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.molbrainres.2004.07.002","article-title":"Effect of transgene copy number on survival in the G93A SOD1 transgenic mouse model of ALS","volume":"130","author":"Alexander","year":"2004","journal-title":"Mol. Brain Res."},{"key":"10.1016\/j.nbd.2026.107396_bb0010","author":"ALS Association T"},{"key":"10.1016\/j.nbd.2026.107396_bb0015","author":"ALSoD A"},{"issue":"17","key":"10.1016\/j.nbd.2026.107396_bb0020","doi-asserted-by":"crossref","first-page":"6793","DOI":"10.1523\/JNEUROSCI.23-17-06793.2003","article-title":"N-type calcium channel \u03b11B subunit (CaV2.2) Knock-out mice display hyperactivity and vigilance state differences","volume":"23","author":"Beuckmann","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2026.107396_bb0025","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.nbd.2016.04.009","article-title":"Voltage-gated calcium channels are abnormal in cultured spinal motoneurons in the G93A-SOD1 transgenic mouse model of ALS","volume":"93","author":"Chang","year":"2016","journal-title":"Neurobiol. Dis."},{"issue":"1","key":"10.1016\/j.nbd.2026.107396_bb0030","doi-asserted-by":"crossref","first-page":"115","DOI":"10.3233\/JAD-170775","article-title":"Comprehensive characterization of the pyroglutamate amyloid-\u03b2 induced motor neurodegenerative phenotype of TBA2.1 mice","volume":"63","author":"Dunkelmann","year":"2018","journal-title":"J. Alzheimer\u2019s Dis"},{"key":"10.1016\/j.nbd.2026.107396_bb0035","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2024.1422943","article-title":"Timeline of hypoglossal motor neuron death and intrinsic tongue muscle denervation in high-copy number SOD1G93A mice","volume":"15","author":"Fogarty","year":"2024","journal-title":"Front. Neurol."},{"issue":"1","key":"10.1016\/j.nbd.2026.107396_bb0040","doi-asserted-by":"crossref","first-page":"6724","DOI":"10.1038\/s41598-019-43164-z","article-title":"SOD1-positive aggregate accumulation in the CNS predicts slower disease progression and increased longevity in a mutant SOD1 mouse model of ALS","volume":"9","author":"Gill","year":"2019","journal-title":"Sci. Rep."},{"issue":"5","key":"10.1016\/j.nbd.2026.107396_bb0045","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1016\/j.ajhg.2019.03.005","article-title":"Bi-allelic loss-of-function CACNA1B mutations in progressive epilepsy-dyskinesia","volume":"104","author":"Gorman","year":"2019","journal-title":"Am. J. Hum. Genet."},{"issue":"3","key":"10.1016\/j.nbd.2026.107396_bb0050","doi-asserted-by":"crossref","DOI":"10.1093\/braincomms\/fcac145","article-title":"Prionoids in amyotrophic lateral sclerosis","volume":"4","author":"Gosset","year":"2022","journal-title":"Brain Commun."},{"issue":"5166","key":"10.1016\/j.nbd.2026.107396_bb0055","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1126\/science.8209258","article-title":"Motor neuron degeneration in mice that express a human cu, Zn superoxide dismutase mutation","volume":"264","author":"Gurney","year":"1994","journal-title":"Science"},{"issue":"11","key":"10.1016\/j.nbd.2026.107396_bb0060","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1038\/nrneurol.2011.153","article-title":"Clinical diagnosis and management of amyotrophic lateral sclerosis","volume":"7","author":"Hardiman","year":"2011","journal-title":"Nat. Rev. Neurol."},{"issue":"11","key":"10.1016\/j.nbd.2026.107396_bb0065","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1097\/00001756-200108080-00027","article-title":"Differential nociceptive responses in mice lacking the \u03b11B subunit of n-type ca2+ channels","volume":"12","author":"Hatakeyama","year":"2001","journal-title":"Neuroreport"},{"key":"10.1016\/j.nbd.2026.107396_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.ceca.2019.102059","article-title":"Involvement of n-type ca2+ channel in microglial activation and its implications to aging-induced exaggerated cytokine response","volume":"82","author":"Huntula","year":"2019","journal-title":"Cell Calcium"},{"issue":"9","key":"10.1016\/j.nbd.2026.107396_bb0075","doi-asserted-by":"crossref","first-page":"5323","DOI":"10.1073\/pnas.081089398","article-title":"Functional disorders of the sympathetic nervous system in mice lacking the \u03b11B subunit (CaV2.2) of n-type calcium channels","volume":"98","author":"Ino","year":"2001","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"1","key":"10.1016\/j.nbd.2026.107396_bb0080","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1523\/JNEUROSCI.20-01-00059.2000","article-title":"Developmental changes in calcium channel types mediating central synaptic transmission","volume":"20","author":"Iwasaki","year":"2000","journal-title":"J. Neurosci."},{"issue":"2","key":"10.1016\/j.nbd.2026.107396_bb0085","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1002\/med.21528","article-title":"Riluzole and edaravone: a tale of two amyotrophic lateral sclerosis drugs","volume":"39","author":"Jaiswal","year":"2019","journal-title":"Med. Res. Rev."},{"issue":"2","key":"10.1016\/j.nbd.2026.107396_bb0090","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1177\/15357597251317898","article-title":"Breaking the synaptic vesicle cycle: mechanistic insights into presynaptic dysfunctions in epilepsy","volume":"25","author":"Jiang","year":"2025","journal-title":"Epilepsy Curr."},{"issue":"2","key":"10.1016\/j.nbd.2026.107396_bb0095","doi-asserted-by":"crossref","first-page":"101","DOI":"10.4149\/gpb_2019004","article-title":"Structure, function and regulation of CaV2.2 n-type calcium channels","volume":"38","author":"Jurkovicova-Tarabova","year":"2019","journal-title":"Gen. Physiol. Biophys."},{"issue":"7","key":"10.1016\/j.nbd.2026.107396_bb0100","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/s40261-024-01371-1","article-title":"Sodium phenylbutyrate and tauroursodeoxycholic acid: a story of hope turned to disappointment in amyotrophic lateral sclerosis treatment","volume":"44","author":"Ketabforoush","year":"2024","journal-title":"Clin. Drug Investig."},{"issue":"12","key":"10.1016\/j.nbd.2026.107396_bb0105","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1111\/bph.16309","article-title":"An orally available CaV2. 2 calcium channel inhibitor for the treatment of neuropathic pain","volume":"181","author":"Kutzsche","year":"2024","journal-title":"Br. J. Pharmacol."},{"issue":"10","key":"10.1016\/j.nbd.2026.107396_bb0110","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1111\/ene.14393","article-title":"Amyotrophic lateral sclerosis: a clinical review","volume":"27","author":"Masrori","year":"2020","journal-title":"Eur. J. Neurol."},{"issue":"1","key":"10.1016\/j.nbd.2026.107396_bb0115","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0165-0270(96)02211-X","article-title":"Pole test is a useful method for evaluating the mouse movement disorder caused by striatal dopamine depletion","volume":"73","author":"Matsuura","year":"1997","journal-title":"J. Neurosci. Methods"},{"issue":"8","key":"10.1016\/j.nbd.2026.107396_bb0120","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0023244","article-title":"Optimised and rapid pre-clinical screening in the SOD1G93A transgenic mouse model of amyotrophic lateral sclerosis (ALS)","volume":"6","author":"Mead","year":"2011","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/j.nbd.2026.107396_bb0125","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1056\/NEJMoa2204705","article-title":"Trial of antisense oligonucleotide tofersen for SOD1 ALS","volume":"387","author":"Miller","year":"2022","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.nbd.2026.107396_bb0130","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/S1050-1738(02)00173-1","article-title":"Ca2+ channel \u03b11B subunit (CaV2.2) knockout mouse reveals a predominant role of N-type channels in the sympathetic regulation of the circulatory system","volume":"12","author":"Mori","year":"2002","journal-title":"Trends Cardiovasc. Med."},{"issue":"1","key":"10.1016\/j.nbd.2026.107396_bb0135","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.bbr.2009.11.042","article-title":"Behavioral and neurochemical characterization of mice deficient in the n-type Ca2+ channel \u03b11B subunit","volume":"208","author":"Nakagawasai","year":"2010","journal-title":"Behav. Brain Res."},{"issue":"17","key":"10.1016\/j.nbd.2026.107396_bb0140","doi-asserted-by":"crossref","first-page":"3073","DOI":"10.1242\/jcs.113.17.3073","article-title":"Involvement of iba1 in membrane ruffling and phagocytosis of macrophages\/microglia","volume":"113","author":"Ohsawa","year":"2000","journal-title":"J. Cell Sci."},{"issue":"10","key":"10.1016\/j.nbd.2026.107396_bb0145","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1056\/NEJMoa1916945","article-title":"Trial of sodium phenylbutyrate\u2013taurursodiol for amyotrophic lateral sclerosis","volume":"383","author":"Paganoni","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.nbd.2026.107396_bb0150","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1002\/mus.27091","article-title":"Long-term survival of participants in the CENTAUR trial of sodium phenylbutyrate-taurursodiol in amyotrophic lateral sclerosis","volume":"63","author":"Paganoni","year":"2021","journal-title":"Muscle Nerve"},{"issue":"9","key":"10.1016\/j.nbd.2026.107396_bb0155","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.3390\/diagnostics11091546","article-title":"Oxidative stress as a therapeutic target in amyotrophic lateral sclerosis: opportunities and limitations","volume":"11","author":"Park","year":"2021","journal-title":"Diagnostics"},{"key":"10.1016\/j.nbd.2026.107396_bb0160","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.expneurol.2012.11.002","article-title":"Over-expression of n-type calcium channels in cortical neurons from a mouse model of amyotrophic lateral sclerosis","volume":"247","author":"Pieri","year":"2013","journal-title":"Exp. Neurol."},{"issue":"6","key":"10.1016\/j.nbd.2026.107396_bb0165","doi-asserted-by":"crossref","DOI":"10.3390\/molecules26061590","article-title":"A novel anti-inflammatory d-peptide inhibits disease phenotype progression in an ALS mouse model","volume":"26","author":"Post","year":"2021","journal-title":"Molecules"},{"issue":"13","key":"10.1016\/j.nbd.2026.107396_bb0170","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22137066","article-title":"Oral treatment with RD2RD2 impedes development of motoric phenotype and delays symptom onset in SOD1G93A transgenic mice","volume":"22","author":"Post","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.nbd.2026.107396_bb0175","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.expneurol.2014.07.021","article-title":"Focality, stochasticity and neuroanatomic propagation in ALS pathogenesis","volume":"262","author":"Ravits","year":"2014","journal-title":"Exp. Neurol."},{"issue":"10","key":"10.1016\/j.nbd.2026.107396_bb0180","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1093\/emboj\/20.10.2349","article-title":"Suppression of inflammatory and neuropathic pain symptoms in mice lacking the n-type Ca2+ channel","volume":"20","author":"Saegusa","year":"2001","journal-title":"EMBO J."},{"issue":"2","key":"10.1016\/j.nbd.2026.107396_bb0185","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1006\/bbrc.2001.5388","article-title":"Iba1 is an actin-cross-linking protein in macrophages\/microglia","volume":"286","author":"Sasaki","year":"2001","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"7","key":"10.1016\/j.nbd.2026.107396_bb0190","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/nmeth.2089","article-title":"NIH image to ImageJ: 25 years of image analysis","volume":"9","author":"Schneider","year":"2012","journal-title":"Nat. Methods"},{"issue":"2","key":"10.1016\/j.nbd.2026.107396_bb0195","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.neuroscience.2007.10.017","article-title":"Time-course and characterization of orolingual motor deficits in B6SJL-Tg (SOD1-G93A) 1Gur\/J mice","volume":"151","author":"Smittkamp","year":"2008","journal-title":"Neuroscience"},{"issue":"10","key":"10.1016\/j.nbd.2026.107396_bb0200","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1136\/jnnp-2021-328550","article-title":"Relationship between motor cortical and peripheral axonal hyperexcitability in amyotrophic lateral sclerosis","volume":"93","author":"Suzuki","year":"2022","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.nbd.2026.107396_bb0205","doi-asserted-by":"crossref","first-page":"62","DOI":"10.2174\/1875397300802010062","article-title":"Glutamatergic synaptic dysfunction and obsessive-compulsive disorder","volume":"2","author":"Ting","year":"2008","journal-title":"Curr. Chem. Genomics"},{"issue":"4","key":"10.1016\/j.nbd.2026.107396_bb0210","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1002\/brb3.143","article-title":"Characterization of early pathogenesis in the SOD1G93A mouse model of ALS: Part I, background and methods","volume":"3","author":"Vinsant","year":"2013","journal-title":"Brain Behav."},{"issue":"4","key":"10.1016\/j.nbd.2026.107396_bb0215","doi-asserted-by":"crossref","first-page":"995","DOI":"10.3390\/biomedicines11040995","article-title":"Oral treatment with d-RD2RD2 impedes early disease mechanisms in SOD1*G93A transgenic mice but does not prolong survival","volume":"11","author":"Wintz","year":"2023","journal-title":"Biomedicines"},{"issue":"1","key":"10.1016\/j.nbd.2026.107396_bb0220","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0168-1591(98)00150-6","article-title":"Effect of feed and environmental enrichment on development of stereotypic wire-gnawing in laboratory mice","volume":"60","author":"W\u00fcrbel","year":"1998","journal-title":"Appl. Anim. Behav. Sci."},{"key":"10.1016\/j.nbd.2026.107396_bb0225","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.jad.2025.03.088","article-title":"Neurobiological differences in early-onset obsessive-compulsive disorder: a study of the glutamatergic system based on functional magnetic resonance spectroscopy","volume":"379","author":"Xiao","year":"2025","journal-title":"J. Affect. Disord."},{"issue":"10","key":"10.1016\/j.nbd.2026.107396_bb0230","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.3390\/biology12101307","article-title":"Microglia and astrocytes in amyotrophic lateral sclerosis: disease-associated states, pathological roles, and therapeutic potential","volume":"12","author":"You","year":"2023","journal-title":"Biology"},{"key":"10.1016\/j.nbd.2026.107396_bb0235","doi-asserted-by":"crossref","DOI":"10.4103\/2152-7806.169561","article-title":"A comprehensive review of amyotrophic lateral sclerosis","volume":"6","author":"Zarei","year":"2015","journal-title":"Surg. Neurol. Int."}],"container-title":["Neurobiology of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996126001415?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996126001415?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T11:29:29Z","timestamp":1785151769000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969996126001415"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":47,"alternative-id":["S0969996126001415"],"URL":"https:\/\/doi.org\/10.1016\/j.nbd.2026.107396","relation":{},"ISSN":["0969-9961"],"issn-type":[{"value":"0969-9961","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Elucidation of the influence of the CaV2.2 calcium channel on ALS disease progression in the SOD1*G93A mouse model","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nbd.2026.107396","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"107396"}}